Rotavirus Clinical Trials

A listing of Rotavirus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 15 clinical trials
Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine

The study will evaluate safety and immunogenicity of LORV (Rotarix and RV3-BB) when TV P2-VP8, a parentally administered rotavirus vaccine is administered either concomitantly or as a prime

  • 0 views
  • 13 Mar, 2021
  • 2 locations
Efficacy Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates

This phase III trial aims to assess the efficacy, safety and immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in neonates, lot-to-lot consistency, and antigen interference with co

  • 0 views
  • 27 Jan, 2021
  • 2 locations
A Trial to Assess the Safety Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India

The trial will be a multinational, randomized, double-blind, double-dummy, endpoint driven, group-sequential, active comparator-controlled study, in which participating infants will be randomized 1:1 to receive either: 1) 90 g of the TV P2-VP8 vaccine IM plus oral placebo, or 2) Rotarix per os (PO) plus IM placebo. Participants will receive …

  • 0 views
  • 15 Apr, 2021
  • 1 location
Treatment of Mild-moderate Clostridium Difficile Infection (CDI)

Patients diagnosed to have mild-moderate CDI will be randomized to receive IM-01 egg-derived anti-C. difficile polyclonal antibodies in increasing dosages, twice daily, for a total of 10 14 days. Resolution of diarrhea and other symptoms and fecal test parameters will be used to assess clinical effectiveness of Immunotherapy with IM-01 …

  • 0 views
  • 23 Jan, 2021
  • 1 location
Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa

Despite the widespread introduction of vaccines against Rotavirus, Rotavirus continues to be a cause of significant morbidity and mortality in the developing world. This study will assess

  • 0 views
  • 28 Apr, 2021
  • 1 location
Response to Rotavirus Vaccine in Infants in Ho Chi Minh City in Vietnam

The primary objective is to measure the effect of host human genetics on the resulting immunological responses and long-term protection following rotavirus immunization of a study population of

rotavirus
rotavirus vaccine
rotarix
vaccination
  • 24 views
  • 21 Jul, 2021
  • 4 locations
Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine

A double blind placebo controlled Phase I/II study to evaluate the safety and immunogenicity of the Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine [BRV-TV

  • 30 views
  • 08 Nov, 2020
  • 1 location
COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients

), influenza H1N1, and rotavirus with good efficacy. This study will evaluate the efficacy of PVP-I as prophylaxis in Coronavirus Disease 2019 (COVID19)-negative front-line health care workers, hospital

coronavirus infection
covid-19
nasopharyngeal swab
SARS
middle east respiratory syndrome
  • 30 views
  • 16 Jun, 2021
  • 1 location
Catalysing the Containment of COVID-19

production, and interferes with SARS-CoV-2 glycosylation. It has been shown to have anti-viral activity against several viruses including Ebola, influenza, hepatitis B and C, rotavirus and norovirus.

hypercytokinemia
oseltamivir
oximetry
respiratory distress
cough
  • 42 views
  • 14 Jun, 2021
  • 4 locations
Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol)

The CDC and WHO have deemed the COVID-19 virus a global pandemic of unprecedented severity in modern times. In 2019, this novel Coronavirus (COVID-19) emerged from the Asian continent and has now caused upwards of 1million deaths and over 6 million infections globally. Currently, the estimated global economic impact is …

  • 4 views
  • 31 Mar, 2021
  • 1 location